TherapeuticsMD (TXMD) Goodwill & Intangibles (2010 - 2026)
TherapeuticsMD (TXMD) posted Goodwill & Intangibles of $3.7 million for Q1 2026, down 2.5% on a QoQ basis from $3.8 million in Q4 2025, and down 11.38% year-over-year from $4.1 million in Q1 2025.
TherapeuticsMD (TXMD) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
TherapeuticsMD's Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $3.7 million for Q1 2026.
- Quarterly Goodwill & Intangibles fell 11.38% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (down 11.38% YoY) and the FY2025 annual result came in at $3.8 million, down 41.04% from the prior year.
- Goodwill & Intangibles was $3.7 million for Q1 2026 at TherapeuticsMD, down from $3.8 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $48.4 million in Q3 2022 and bottomed at $3.7 million in Q1 2026.
- A 5-year average of $12.7 million and a median of $6.4 million in 2024 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2023 — Goodwill & Intangibles slumped 86.26% — and 2025, when it soared 39.06%.
- TherapeuticsMD's Goodwill & Intangibles stood at $8.5 million in 2022, then retreated by 28.6% to $6.1 million in 2023, then advanced by 4.61% to $6.4 million in 2024, then slumped by 41.04% to $3.8 million in 2025, then dropped by 2.5% to $3.7 million in 2026.
- Business Quant data shows TXMD's Goodwill & Intangibles at $3.7 million in Q1 2026, $3.8 million in Q4 2025, and $3.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.67 Mn |
| Dec 31, 2025 | 3.76 Mn |
| Sep 30, 2025 | 3.91 Mn |
| Jun 30, 2025 | 6.29 Mn |
| Mar 31, 2025 | 4.14 Mn |
| Dec 31, 2024 | 6.38 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Jun 30, 2024 | 4.52 Mn |
| Mar 31, 2024 | 5.97 Mn |
| Dec 31, 2023 | 6.10 Mn |
| Sep 30, 2023 | 6.66 Mn |
| Jun 30, 2023 | 6.77 Mn |
| Mar 31, 2023 | 6.88 Mn |
| Dec 31, 2022 | 8.54 Mn |
| Sep 30, 2022 | 48.45 Mn |
| Jun 30, 2022 | 38.72 Mn |
| Mar 31, 2022 | 48.36 Mn |
| Dec 31, 2021 | 8.19 Mn |
| Sep 30, 2021 | 46.67 Mn |
| Jun 30, 2021 | 46.42 Mn |